294 Strategies to Manage Radiation Therapy Wait Time “Ready-to-Treat to Start of Treatment” Performance in Ontario von Loudon, James, MacDonald, Tara, Stillwaugh, Laurie, Singh, Richard, de Dios, Dennis Vergel, Sodhi, Sandi, Diffey, Melissa, Mathurin, Tammy, Pidgeon, Brandee, Blanchette, Rob, King, Melisa, Tam, Kit, Chan, Jackson, Russell, Steve, Divanbeigi, Lorella, Tsang, Yat, Black, Christine, D’Alimonte, Laura, Linke, Mellissa, Hart, Margaret, Liszewski, Brian, Gutierrez, Eric

Volltext

40 Canagliflozin, a New Anti-Diabetic Agent Targeting Cellular Metabolism, Suppresses Survival and Enhances the Response of Non-Small Cell Lung Cancer (NSCLC) to Radiotherapy von Biziotis, Olga-Demetra, Tsakiridis, Evangelia - Evelyn, Broadfield, Lindsay, Farrell, Thomas, Menjolian, Gabe, Mathurin, Tammy, Mekhaeil, Bassem, Zacharidis, Panagiotis, Muti, Paola, Abdulkarim, Bassam, Steinberg, Gregory, Tsakiridis, Theodoros

Volltext

167 The New Diabetes Drug Canagliflozin Enhances the Response of Prostate Cancer to Radiotherapy von Mekhaeil, Bassem, Zacharidis, Panagiotis, Tsakiridis, Evelyn, Biziotis, Olga-Demetra, Broadfield, Lindsay, Menjolian, Gabe, Mathurin, Tammy, Farrell, Thomas, Muti, Paola, Liu, Stanley, Steinberg, Gregory, Tsakiridis, Theodoros

Volltext

Salicylate enhances the response of prostate cancer to radiotherapy von Broadfield, Lindsay A., Marcinko, Katarina, Tsakiridis, Evangelia, Zacharidis, Panayiotis G., Villani, Linda, Lally, James S. V., Menjolian, Gabe, Maharaj, Danitra, Mathurin, Tammy, Smoke, Marcia, Farrell, Thomas, Muti, Paola, Steinberg, Gregory R., Tsakiridis, Theodoros

Volltext